Sign in

CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
981448305
Phone
646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,710,812
in 3 filings, $1.7M under 10b5-1 plans

Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-02 Hukkelhoven Ellen Director Grant or award · Stock Option (right to buy) +25,000 25,000
2020-06-02 LEVINE ARNOLD J Director Grant or award · Stock Option (right to buy) +25,000 25,000
2020-06-02 Harris Keith R. Director Grant or award · Stock Option (right to buy) +25,000 25,000
2020-06-02 Seligman Nicole Director Grant or award · Stock Option (right to buy) +25,000 25,000
2020-05-22 Forbes Alexandria President & CEO Sale −9,125 $15.18 $139K 1,418,081
2020-05-21 Giroux Richard CFO & COO Sale −11,786 $15.16 $179K 1,064,518
2020-05-21 Forbes Alexandria President & CEO Sale −14,732 $15.18 $224K 1,427,206
2020-05-20 Giroux Richard CFO & COO Sale −6,143 $15.03 $92K 1,076,304
2020-05-20 Forbes Alexandria President & CEO Sale −6,143 $15.04 $92K 1,441,938
2020-05-13 Giroux Richard CFO & COO Sale −71 $15.38 $1K 1,082,447
2020-04-20 Giroux Richard CFO & COO Gift −350 1,167,518

Page 21 of 21 · 411 trades